Table 3.
Treatment and follow-up details (available in 6 cases)
| S No | Diagnosis | Treatment | Response | Complications during therapy | Follow-up (FU) |
|---|---|---|---|---|---|
| 1 | HCL by immunophenotyping | Cladribine | Complete remission | Febrile neutropenia | Complete remission on FU—2 years |
| 2 | HCL by immunophenotyping | Cladribine | Residual disease in BM, again put on cladribine | Alveolitis | Complete remission on FU—3 years |
| 3 | HCL by immunophenotyping | Cladribine | Complete remission | Febrile neutropenia | Complete remission on FU—1½ years |
| 4 | HCL by immunophenotyping | Cladribine | Died during treatment | Intracranial bleed | – |
| 5 | HCL by morphology, TRAP | Interferon | Relapsed after 9 years, started on cladribine | Miliary tuberculosis | Complete remission on FU—2 years |
| 6 | HCL-v by immunophenotyping | Cladribine | No response, rituximab added | Disease persisted | Lost to FU after 1½ years |